AbbVie’s Rinvoq expansion hits a 2nd snag as FDA delays $2B atopic dermatitis ruling

AbbVie’s Rinvoq expansion hits a 2nd snag as FDA delays $2B atopic dermatitis ruling
aliu
Mon, 04/05/2021 – 09:16